Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Anti-GABAB1 Receptor Antibody from AbboMax

Published: Thursday, December 19, 2013
Last Updated: Thursday, December 19, 2013
Bookmark and Share
Recent progress in neuroscience research from the Company.

Neurotransmitters are chemical messengers that transmit and modulate signals from neurons to other cells of the brain and body across a synapse. When a neurotransmitter binds to its corresponding receptor, it activates or inhibits the receptor's associated pathway.

GABA, the most prevalent inhibitory neurotransmitter in the mammalian central nervous system, plays an essential role in regulating vital neurological functions. GABA’s natural function is to reduce the activity of the neurons to which it binds through GABA receptors (GABARs).

Regulation of both excitatory and inhibitory synaptic transmission is critical for proper nervous system function. GABARs are promising drug targets for a wide spectrum of psychiatric and neurological disorders. They are involved in sedative and anxiolytic activities.

Enhancement of GABA signaling has been demonstrated in patients with central nervous system hypersomnias. GABA-ergic disturbances are hallmark features of schizophrenia and other neuropsychiatric disorders.

GABA-ergic system has been associated consistently with atypicalities in autism and aggressive behavior. Modulators of the GABARs may be useful in the treatment of visual, sleep, and cognitive disorders.

GABARs have been associated with seizures and memory dysfunction when disrupted. The up-regulations of GABA in the brain may lead to an antiepileptic effect. The cerebellar cortex, the brain region responsible for motor coordination and learning expresses a high density of GABARs.

Repeated alcohol exposure during the third trimester of pregnancy increases expression of GABARs in cerebellar granule neurons and delays motor development in rats. Ethanol significantly reduces the brain metabolism, probably via action at specific GABARs. These receptors an important role in the neuroprotective effects of anthocyanins against ethanol.

Interestingly, increased expression of GABARs has been detected in several human cancer cells and tissues.

It was demonstrated that the absence of functional GABARs disturbs glucose homeostasis in mice.

AbboMax offers new anti-GABAB1 receptor polyclonal antibody as well as an extensive collection of neuroscience related antibodies.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

AbboMax Announces the Availability of new Methyl- Specific Antibodies for the Epigenetics Research
Company offers nine novel anti- histone H3 antibodies specific for a mono-, di-, or tri-methylated state of Lys4, Lys9, and Lys27.
Friday, October 22, 2010
Scientific News
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!